Back
Recursion Pharmaceuticals Stock Price Chart
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
33
RXRX
Recursion Pharmaceuticals
Last Price:
$4.36
Seasonality Move:
9.51%
7 Day Trial
ALL ACCESS PASS
$
7
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.29 | Sell |
| 20-day SMA: | 4.43 | Sell |
| 50-day SMA: | 5.07 | Sell |
| 200-day SMA: | 6.51 | Sell |
| 8-day EMA: | 4.32 | Sell |
| 20-day EMA: | 4.52 | Sell |
| 50-day EMA: | 5.12 | Sell |
| 200-day EMA: | 6.51 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 40.49 | Sell |
| Chaikin Money Flow: | -9047243 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.09 - 5.27) | Sell |
| Bollinger Bands (100): | (4.71 - 7.81) | Sell |
Recursion Pharmaceuticals Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 4.18 while RXRX 8-day simple moving average is 4.29, which is a Sell signal.
-
The stock price of RXRX is 4.18 while Recursion Pharmaceuticals 20-day SMA is 4.43, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day simple moving average is 5.07 while RXRX share price is 4.18, making it a Sell technically.
-
RXRX stock price is 4.18 and Recursion Pharmaceuticals 200-day simple moving average is 6.51, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
33
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $4.18. The Score for RXRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.7B
Price in USD:
4.18
Share Volume:
20.6M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
12.36
52-Week Low:
3.79
Sell
33
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 4.18 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 4.18 while RXRX 8-day exponential moving average is 4.32, which is a Sell signal.
-
The stock price of RXRX is 4.18 while Recursion Pharmaceuticals 20-day EMA is 4.52, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day exponential moving average is 5.12 while RXRX share price is 4.18, making it a Sell technically.
-
RXRX stock price is 4.18 and Recursion Pharmaceuticals 200-day simple moving average is 6.51, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.25 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Recursion Pharmaceuticals is a Sell
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 40.49, which suggest Recursion Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is (4.09 - 5.27), which suggest Recursion Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is (4.71 - 7.81), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.